Myriad Genetics Reports Fiscal Fourth-Quarter and Full-Year 2018 Financial Results - Nasdaq

Submitted by Anonymous (not verified) on Tue, 08/21/2018 - 20:05

Myriad Genetics Reports Fiscal Fourth-Quarter and Full-Year 2018 Financial ResultsNasdaqPresented the results from the GeneSight GUIDED randomized controlled trial at the American Psychiatric Association annual meeting. The landmark study showed that patients receiving GeneSight had significantly better outcomes with a 50 percent increase ...and more »